Literature DB >> 23599608

Tc99m sulfur colloid scintigraphy in differentiating noncirrhotic portal fibrosis from cirrhosis liver.

Viroj Wiwanitkit1.   

Abstract

Entities:  

Year:  2012        PMID: 23599608      PMCID: PMC3628272          DOI: 10.4103/0972-3919.108898

Source DB:  PubMed          Journal:  Indian J Nucl Med        ISSN: 0974-0244


× No keyword cloud information.
Sir, I read the recent publication on ‘Tc99m sulfur colloid scintigraphy in differentiating non-cirrhotic portal fibrosis (NCPF) from cirrhosis liver’ with great interest.[1] Chakraborty et al., concluded that “Tc99m sulfur colloid liver scan is a non-invasive procedure having a useful adjunctive role in clinical differentiation of cirrhosis from NCPF.”[1] Based on the findings, I agree with the authors. However, I would like to share some facts on technetium-99m (Tc99m). The problem with some conditions that mimic the results of Tc99m is reported.[2] The complementary use of chest X-ray is suggested.[3] Although this is not a common case, it should be noted and kept in mind.
  3 in total

1.  Hydronephrosis mimicking metastatic disease on a Tc-99m sulfur colloid liver/spleen scan.

Authors:  R B Duong; H Nishiyama; D T Volarich; M L Hanslits
Journal:  Clin Nucl Med       Date:  1983-05       Impact factor: 7.794

2.  Complementary role of chest roentgenogram in interpretation of Tc-99m sulfur colloid liver scan.

Authors:  J J Vesely; C Bekerman; S Pinsky
Journal:  Clin Nucl Med       Date:  1984-08       Impact factor: 7.794

3.  Role of Tc99m sulfur colloid scintigraphy in differentiating non-cirrhotic portal fibrosis from cirrhosis liver.

Authors:  Dhritiman Chakraborty; Hejjaji Venkataramarao Sunil; Bhagwant Rai Mittal; Anish Bhattacharya; Baljinder Singh; Yogesh Chawla
Journal:  Indian J Nucl Med       Date:  2010-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.